Table of contents
June 2024 - Volume 83 - Suppl 1
EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria
- Scientific Abstracts
- Oral Presentations
- Abstract Plenary
- "Asymptomatic" Hyperuricemia: Innocent bystander or menacing foe?
- 75th Anniversary of Glucocorticoids - what have we learnt?
- Autoinflammation: Crossroads of Autoinflammation and Autoimmunity
- Axial Involvement in PsA and SpA
- Basic Abstract Sessions: Advanced synovial tissue and blood analysis in Inflammatory Arthritis
- Basic Abstract Sessions: Connective Tissue Diseases
- Basic Abstract Sessions: Immune cell activation across inflammatory diseases
- Basic Abstract Sessions: Local tissue cell activation
- Basic Abstract Sessions: New mechanisms in vasculitis and PMR
- Basic Abstract Sessions: New pathways in Sjön's disease
- Basic Abstract Sessions: Pathophysiology in systemic sclerosis disease
- Basic Abstract Sessions: RA pathogenesis and novel therapeutic targets
- Building In Vitro Organs
- Checkpoint Inhibition and Autoimmune Issues
- Clinical Abstract Sessions: Advances in Giant Cell Arteritis and Polymyalgia Rheumatica
- Clinical Abstract Sessions: Autoinflammation with a focus on Vexas
- Clinical Abstract Sessions: Clinical aspects of Systemic sclerosis
- Clinical Abstract Sessions: Clinical Aspects of Rheumatoid Arthritis
- Clinical Abstract Sessions: Clinical trials and other treatment aspects in Rheumatoid arthritis
- Clinical Abstract Sessions: Crystal related disorders - clinical aspects and treatment
- Clinical Abstract Sessions: Diagnosis and management of inflammatory myopathies
- Clinical Abstract Sessions: Difficult-to-treat and multidrug resistant Rheumatoid Arthritis
- Clinical Abstract Sessions: Evaluating the complexities of Antiphospholipid Syndrome
- Clinical Abstract Sessions: How modern technology helps us understand SpA & PsA
- Clinical Abstract Sessions: Imaging aspects of SpA & PsA
- Clinical Abstract Sessions: New developments in Osteoarthritis
- Clinical Abstract Sessions: New targets and new treatments in Sjön's disease
- Clinical Abstract Sessions: Novel digital technologies and machine learning
- Clinical Abstract Sessions: Novel treatment avenues in SLE
- Clinical Abstract Sessions: Risk factors and treatment in osteoporosis
- Clinical Abstract Sessions: SpA & PsA - Treatment effects and response prediction
- Clinical Abstract Sessions: Systemic lupus and MCTD - Diagnosing and managing complex diseases
- Clinical Abstract Sessions: Systemic Sclerosis - Imaging and biomarkers
- Clinical Abstract Sessions: Treating clinical aspects of SpA and PsA
- Clinical Abstract Sessions: Treatment options in Systemic sclerosis
- Clinical Abstract Sessions: Vasculitis across different vessel sizes
- Clinical Abstract Sessions: Rheumatoid arthritis - A focus on pain and prognosis
- DMOADs and Pro-regenerative Therapies for Osteoarthritis: where are we?
- Inflammaging and Cellular Senescence in Rheumatic and Musculoskeletal Diseases
- Inflammatory Myopathies
- Macrophages in Rheumatoid Arthritis: again and again
- Management of Still's Disease across the Life-Span
- Metabolic Reprogramming in Autoimmunity
- Novel Mechanisms of Pain Sensitization
- Precision Medicine and Novel Targets in SSc
- Sjögren’s Syndrome
- Tapering and Withdrawal of Treatment in RMDs
- Unravelling the Extracellular Matrix
- What Autoantigens do T cells really see in the Rheumatic Diseases?
- What you wanted to know about Mitochondria
- Paediatric Abstract Sessions: Advances in JIA Research
- Paediatric Abstract Sessions: Paediatric Rheumatology Presentations
- Clinical Abstract Sessions: Vasculitis across different vessel sizes
- Oral Abstract Sessions: Late-Breaking Abstracts
- Oral Abstract Sessions: Late-Breaking Abstracts 2
- Poster Tours
- Basic Poster Tours: Basic and translational research in Inflammatory Myopathies
- Basic Poster Tours: Unveiling the Interplay of Immune Modulators in Arthritis
- Basic Poster Tours: What is new in Osteoarthritis?
- Basic Poster Tours: Impact of therapy on lupus immunity
- Basic Poster Tours: Molecular insights into PsA and SpA
- Basic Poster Tours: New pathophysiological concepts of Vasculitis
- Basic Poster Tours: New tools and biomarkers in Sjön's disease
- Basic Poster Tours: Pathophysiological concepts in fibrosis
- Basic Poster Tours: Pathophysiological concepts in Lupus and lupus nephritis
- Basic Poster Tours: Patient stratification and novel targets in Rheumatoid Arthritis
- Basic Poster Tours: Rheumatoid Arthritis aetiology and pathogenesis
- Basic Poster Tours: What can we learn from basic and translational research in Gout (or Crystal Related Disorders)
- Basic Poster Tours: What did we learn from immune responses to COVID-19
- Clinical Poster Tours: Recent advances in pain
- Clinical Poster Tours: Systemic lupus - Of old and new therapies
- Clinical Poster Tours: Systemic Sclerosis I
- Clinical Poster Tours: Systemic Sclerosis II
- Clinical Poster Tours: Treatment of Spondyloarthritis
- Clinical Poster Tours: Vexas syndrome and
- autoinflammatory disease spectrum
- Clinical Poster Tours: Clinical advances in Sjön's diseases
- Clinical Poster Tours: Clinical aspects of crystal arthropathies
- Clinical Poster Tours: Clinical aspects of psoriatic arthritis
- Clinical Poster Tours: Clinical aspects of small vessel vasculitis - Part 1
- Clinical Poster Tours: Clinical aspects of small vessel vasculitis - Part 2
- Clinical Poster Tours: Clinical studies in osteoarthritis
- Clinical Poster Tours: Facets of Systemic lupus
- Clinical Poster Tours: Gout treatment in 2024
- Clinical Poster Tours: IgG4 Related Disease
- Clinical Poster Tours: Immune checkpoint inhibitors and infection related arthritis
- Clinical Poster Tours: Management of RMDs in the 'Global South'
- Clinical Poster Tours: Miscellaneous in Vasculitis
- Clinical Poster Tours: Novel developments in GCA-PMR spectrum disease
- Clinical Poster Tours: Novelties in Takayasu arteritis and Giant Cell arteritis
- Clinical Poster Tours: Rheumatoid Arthritis I
- Clinical Poster Tours: Rheumatoid Arthritis II
- Clinical Poster Tours: Rheumatoid Arthritis III
- Clinical Poster Tours: Risk stratification in
- metabolic bone diseases
- Clinical Poster Tours: Spondyloarthritis I
- Clinical Poster Tours: Spondyloarthritis II
- Clinical Poster Tours: Treatment Options in
- Metabolic bone diseases and Osteoporosis
- Paediatric Poster Tours: Novel developments in paediatric rheumatology
- Public Health Poster Tour
- Poster View
- Antiphospholipid syndrome
- Autoinflammatory diseases, Vexas and other monogenic diseases
- Behcet`s disease
- COVID-19
- Crystal related disorders
- Pain in rheumatic diseases, including fibromyalgia
- Immunodeficiency
- Infection-related rheumatic diseases
- Inflammatory arthritis
- Inflammatory myopathies
- Juvenile idiopathic arthritis
- Metabolic bone diseases and osteoporosis
- Mixed connective tissue disease
- Osteoarthritis and other mechanical musculoskeletal problems
- Other connective tissue diseases
- Psoriatic arthritis
- Rheumatoid arthritis
- Rheumatoid arthritis
- Sarcoidosis
- Sjön's syndrome
- Spondyloarthritis
- Systemic lupus erythematosus
- Systemic sclerosis
- Vasculitis, small and medium size vessels
- Vasculitis, large vessels including polymyalgia rheumatica
- Public health
- Other diseases
- Across diseases
- All Diseases
- Publication only
- Antiphospholipid syndrome
- Autoinflammatory diseases, Vexas and other monogenic diseases
- Behcet`s disease
- COVID-19
- Crystal related disorders
- Pain in rheumatic diseases, including fibromyalgia
- Immunodeficiency
- Infection-related rheumatic diseases
- Infection-related rheumatic diseases
- Inflammatory arthritis
- Inflammatory myopathies
- Juvenile idiopathic arthritis
- Metabolic bone diseases and osteoporosis
- Mixed connective tissue disease
- Osteoarthritis and other mechanical musculoskeletal problems
- Other connective tissue diseases
- Psoriatic arthritis
- Rheumatoid arthritis
- Sarcoidosis
- Sjön`s syndrome
- Spondyloarthritis
- Systemic lupus erythematosus
- Systemic sclerosis
- Vasculitis, small and medium size vessels
- Vasculitis, large vessels including polymyalgia rheumatica
- Public health
- Other diseases
- Across diseases
- All Diseases
- Oral Presentations
- Health Professionals in Rheumatology Abstracts
- Oral Presentations
- Abstract Plenary
- From Anxiety to Empowerment: Minimising nocebo effects in Rheumatology
- Obesity in Rheumatic Diseases: the science, the food, and the need for change
- HPR Abstract Sessions: Beyond the clinic walls - Digital interventions and optimising care
- HPR Abstract Sessions: Harnessing the benefits of exercise in RMDs
- Poster Tours
- HPR Poster Tours: Exploring the Spectrum of HPR Work 1
- HPR Poster Tours: Exploring the Spectrum of HPR Work 2
- Poster View
- HPR Measuring health
- HPR Epidemiology and public health
- HPR Interventions
- HPR Patients perspectives
- HPR Implementation and service evaluation
- HPR Professional education, training, and competencies
- Publication Only
- HPR Measuring health
- HPR Epidemiology and public health
- HPR Interventions
- HPR Patients perspectives
- HPR Implementation and service evaluation
- HPR Professional education, training, and competencies
- Oral Presentations
- People with Arthritis and Rheumatism in Europe Abstracts
- Oral Presentations
- Abstract Plenary
- Approaching Primary Care and Rheumatology: from early referral to disease management
- From Child to Adult in One Day: Children and Transition
- Mental Health and Wellbeing: behind the pain
- Newly Diagnosed with an RMD: what should I know?
- Patient Involvement in Research: challenges in AI and medical devices development
- Taking a Holistic View: Multidisciplinary care in rheumatology
- Working with an RMD: Make RMDs work
- PARE Abstract Session: From abstract to concrete – the variety of activities of PARE organisations
- Poster Tours
- Poster View
- Publication Only
- Oral Presentations